Clostridial toxin derivatives and methods for treating pain

Details Clostridial toxin derivatives and methods for treating pain Clostridial toxin derivatives and methods for treating pain

2007-10-26

2010-11-16

Kam, Chih-Min (Department: 1656)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S236100, C424S009100, C514S002600, C514S012200, C530S350000, C530S202000

Reexamination Certificate

active

07833535

ABSTRACT:
Agents for treating pain, methods for producing the agents and methods for treating pain by administration to a patient of a therapeutically effective amount of the agent. The agent can include a clostridial neurotoxin, or a component or fragment or derivative thereof, attached to a targeting moiety, wherein the targeting moiety is selected from a group consisting of transmission compounds which can be released from neurons upon the transmission of pain signals by the neurons, and compounds substantially similar to the transmission compounds.

REFERENCES:
patent: 4189426 (1980-02-01), Li
patent: 4481139 (1984-11-01), Folkers et al.
patent: 4664911 (1987-05-01), Uhr et al.
patent: 4719231 (1988-01-01), Umezawa et al.
patent: 5410019 (1995-04-01), Coy et al.
patent: 5714468 (1998-02-01), Binder
patent: 5744131 (1998-04-01), Edwards et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: 5846216 (1998-12-01), Gonzales et al.
patent: 5861284 (1999-01-01), Nishimura et al.
patent: 5891842 (1999-04-01), Kream
patent: 5965406 (1999-10-01), Murphy
patent: 5989545 (1999-11-01), Foster et al.
patent: 6395513 (2002-05-01), Foster et al.
patent: 6500436 (2002-12-01), Donovan
patent: 6632440 (2003-10-01), Quinn et al.
patent: 6641820 (2003-11-01), Donovan
patent: 7052702 (2006-05-01), Duggan et al.
patent: 7056729 (2006-06-01), Donovan
patent: 7138127 (2006-11-01), Donovan
patent: 7192596 (2007-03-01), Shone et al.
patent: 7244436 (2007-07-01), Donovan
patent: 7244437 (2007-07-01), Donovan
patent: 7262291 (2007-08-01), Donovan
patent: 2003/0180289 (2003-09-01), Foster et al.
patent: 2004/0071736 (2004-04-01), Quinn et al.
patent: 2008/0032930 (2008-02-01), Steward et al.
patent: 2008/0032931 (2008-02-01), Steward et al.
patent: 2008/0081355 (2008-04-01), Dolly et al.
patent: 2008/0161226 (2008-07-01), Steward et al.
patent: 2008/0161543 (2008-07-01), Steward et al.
patent: 2008/0182294 (2008-07-01), Dolly et al.
patent: WO 94/21300 (1994-09-01), None
patent: 9532738 (1995-07-01), None
patent: 9633273 (1996-10-01), None
patent: 9801754 (1998-01-01), None
patent: 9807864 (1998-02-01), None
patent: 9917806 (1999-04-01), None
patent: WO 2004/024909 (2004-03-01), None
patent: WO 2005/023309 (2005-03-01), None
patent: WO 2006/027207 (2006-03-01), None
patent: WO 2006/059093 (2006-06-01), None
patent: WO 2006/059105 (2006-06-01), None
patent: WO2006/059113 (2006-06-01), None
U.S. Appl. No. 11/466,244, filed Aug. 2006, Donovan.
U.S. Appl. No. 11/765,863, filed Jun. 2007, Donovan.
U.S. Appl. No. 11/765,878, filed Jun. 2007, Donovan.
U.S. Appl. No. 11/924,880, filed Oct. 2007, Donovan.
XP-00857076, Mosaic Structres of Neurotoxins Produced from Clostridium botulinum types C and D organisms, Morishi et al, Biochimca et Biophysica Acta, 1307 (1996) 123-126.
XP001011356, Berge, O-G et al, Selective Neurotoxic Lesions of Descending Serotonergic and Noadrenergic Pathways in the Rat, Journal of Neurochemistry; 44(4):1156-1161(1985).
XP001012206, Benoliel, R et al, Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain, Pain; 79(2-3):243-253(1999).
XP001011386, Garzon, J et al, Effect of intrathecal injection of pertusis toxin on substance P norepinephrine and serotonin contents in various neural structures of arthritic rats; Life Sciences; 47(21);1915-1924(1990).
Rummel et al, “The Hcc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interation”, Molecular Microbiology, pp. 631-643, Dec. 15, 2003.
Halpern et al, “Characterization of the receptor-binding domain of tetanus toxin”, Journal of Biological Chemistry, pp. 11188-11192, May 25, 1993.
Balasubramaniam, “Neuropeptide Y Family Of Hormones: Receptor Subtypes and Antagonists”, Peptides, vol. 18, No. 3, pp. 445-457, 1997.
Beck-Sickinger, “Structure-Activity Relationships of Neuropeptide Y Analogues with Respect to Y1and Y2Receptors”, Biopolymers (Peptide Science), vol. 37, pp. 123-142, 1995.
Blomqvist, “Y-receptor subtypes-how many more?”, Trends Neurosci. 20, pp. 294-298, 1997.
Cabrele, “Molecular Characterization of the Ligand-Receptor Interaction of the Neuropeptide Y Family”, Journal of Peptide Science, 6, pp. 97-122, 2000.
Hoyle, “Neuropeptide families and their receptors: evolutionary perspectives1”, Brain Research, 848, pp. 1-25, 1999.
Larhammar et al, “Evolution of the Neuropeptide Y Family and Its Receptorsa”, Annals New York Academy of Sciences, pp. 35-40, vol . 839 (1998).
Larhammar, “Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide”, Regulatory Peptides 61, pp. 1-11, 1996.
Larhammar, “Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide”, Regulatory Peptides 65, pp. 165-174, 1996.
Michel et al, “XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors”, Pharm. Reviews, vol. 50, No. 1, pp. 143-150, 1998.

Affiliated with

Also associated with

Rating

Clostridial toxin derivatives and methods for treating pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Clostridial toxin derivatives and methods for treating pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clostridial toxin derivatives and methods for treating pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4230806